| HRR1 | HRR2 | ||
---|---|---|---|---|
Variable | β | t (p) | β | t (p) |
Cardiovascular risk factors | Â | Â | Â | Â |
 Age | −0.26 | −1.25 (.21) | −0.46 | −1.91 (.06) |
 Triglycerides | −21.69 | −1.48 (.14) | −6.03 | −0.37 (.71) |
 VO2 peak | 0.05 | 0.11 (.91) | 0.45 | −0.98 (.32) |
 Framingham risk score | 0.09 | 0.01 (.99) | −2.72 | −0.25 (.79) |
 Resting SBPa |  |  | −0.07 | −0.69 (.48) |
 HOMAa |  |  | −2.51 | −0.16 (.86) |
Inflammatory markers | Â | Â | Â | Â |
 WBC | −0.57 | −0.66 (.51) | −0.01 | −0.02 (.98) |
 Fibrinogen | −3.18 | −1.36 (.17) | −2.24 | −0.94 (.34) |
 hsCRPb | 0.86 | 0.16 (.87) |  |  |
 ESR | 4.49 | 0.70 (.48) | 6.62 | 0.99 (.32) |
Wellbeing | Â | Â | Â | Â |
 Vitality | 1.27 | 0.98 (.32) | 2.09 | 1.78 (.07) |
 EuroQolb | 33.65 | 1.09 (.27) |  |  |
R2 and p-value of the model | R2 | p | R2 | p |
 | 0.297 | 0.009 | 0.379 | 0.001 |